Not only is a robust and effective postmarket surveillance system a regulatory requirement, just as importantly it provides continuous product feedback, and can reduce costs and demands on resources, while increasing product safety and performance.
Historically, the approach to postmarket surveillance has widely been reactive, and concentrated on collating and reporting adverse events. However, increasingly complex medical devices and new regulatory requirements are shifting the approach to more proactive data gathering and analysis, allowing for early detection of any undesirable effects.
In this webinar learn how you can achieve a competitive edge by early implementation of proactive PMS programs by heading off the tangible costs of down-stream field corrective actions and the very real, yet intangible, cost of customer satisfaction.
Harness the power of automation to execute streamlined end-to-end safety solutions while reducing costs.
Meet the challenge of changing stakeholder demands and increasing cost constraints with IQVIA's integrated technology services and analytics-driven offerings.
.svg){kind=icon}
